RNA-seq of human NSCLCL treated with Alectinib, Lorlatinib or Brigatinib. RNA-seq of human NSCLCL treated with Alectinib, Lorlatinib or Brigatinib
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
To better understand the differences between different ALK inhibitors on ALK positive NSCL cell lines, we performed RNA-seq analysis on samples treated with 3 types of ALK inhibitors: Alectinib, Lorlatinib and Brigatinib
创建时间：
2022-07-27
